Similar Papers

Paper Title
Journal
Date
Author
Global Access to Cancer Medicines
Hye-Young Kwon ... Yujeong Kim
-
Hye-Young Kwon, et. al.Hye-Young Kwon ... Yujeong Kim
01 Jan 2020
“Black box” 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk
Shirley Murphy ... Rosemary Roberts
Journal of Allergy and Clinical Immunology | VOL. 117
Shirley Murphy, et. al.Shirley Murphy ... Rosemary Roberts
29 Dec 2005
Pharmacogenetics in oncology: Where we stand today?
Padmaj S Kulkarni
International Journal of Molecular and Immuno Oncology | VOL. 1
Padmaj S KulkarniPadmaj S Kulkarni
25 Nov 2016
Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response.
Daniel F Carr ... Munir Pirmohamed
British Journal of Clinical Pharmacology | VOL. 87
Daniel F Carr, et. al.Daniel F Carr ... Munir Pirmohamed
30 Jun 2020
View more papers

More From: Current Cancer Therapy Reviews

Paper Title
Journal
Date
Author
Innovation and Implication of CRISPR-Mediated T-cell Engineering in Cancer Immunotherapy: A New Insight
Syeda Areej Imran ... Sumel Ashique
Current Cancer Therapy Reviews | VOL. 21
Syeda Areej Imran, et. al.Syeda Areej Imran ... Sumel Ashique
03 Jun 2025
Association between Socioeconomic Inequality and the Burden of Stomach Cancer in Asia: Insights from the Global Burden of Disease Study 2021
Maryam Haghjou ... Seyed Ali Hosseini
Current Cancer Therapy Reviews | VOL. 21
Maryam Haghjou, et. al.Maryam Haghjou ... Seyed Ali Hosseini
12 May 2025
A Multi-study Meta-analysis Approach to Identifying Genetic Signatures in Lung Cancer Progression
Samira A Farhadi ... Soham Ray
Current Cancer Therapy Reviews | VOL. 21
Samira A Farhadi, et. al.Samira A Farhadi ... Soham Ray
29 Apr 2025
Research Progress of TRIM56 in Tumours
Jie Gao ... Rizhu Li
Current Cancer Therapy Reviews | VOL. 21
Jie Gao, et. al.Jie Gao ... Rizhu Li
29 Apr 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.